Due to the limitation of tissue samples, only three pairs of tumor and NAT tissues were selected for phosphoproteomic assay using mass spectrometry‐based isotope tagging for relative and absolute quantification (iTRAQ). The gene discussed is BRD2; the disease is neoplasm.